| Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ … Z Selmani, A Naji, I Zidi, B Favier, E Gaiffe, L Obert, C Borg, P Saas, ... Stem cells 26 (1), 212-222, 2008 | 1375 | 2008 |
| Evaluation of convalescent plasma for Ebola virus disease in Guinea J Van Griensven, T Edwards, X de Lamballerie, MG Semple, P Gallian, ... New England Journal of Medicine 374 (1), 33-42, 2016 | 645 | 2016 |
| Age of transfused blood in critically ill adults J Lacroix, PC Hébert, DA Fergusson, A Tinmouth, DJ Cook, JC Marshall, ... New England Journal of Medicine 372 (15), 1410-1418, 2015 | 622 | 2015 |
| Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference MM Mueller, H Van Remoortel, P Meybohm, K Aranko, C Aubron, ... Jama 321 (10), 983-997, 2019 | 575 | 2019 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| Administration of herpes simplex–thymidine kinase–expressing donor T cells with a T-cell–depleted allogeneic marrow graft P Tiberghien, C Ferrand, B Lioure, N Milpied, R Angonin, E Deconinck, ... Blood, The Journal of the American Society of Hematology 97 (1), 63-72, 2001 | 348 | 2001 |
| Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19 T Hueso, C Pouderoux, H Péré, AL Beaumont, LA Raillon, F Ader, ... Blood, The Journal of the American Society of Hematology 136 (20), 2290-2295, 2020 | 286 | 2020 |
| All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a … P Fenaux, S Castaigne, H Dombret, E Archimbaud, M Duarte, P Morel, ... | 285 | 1992 |
| A nationwide survey of hepatitis E viral infection in French blood donors JM Mansuy, P Gallian, C Dimeglio, K Saune, C Arnaud, B Pelletier, ... Hepatology 63 (4), 1145-1154, 2016 | 258 | 2016 |
| Risk factors for acute graft-versus-host disease after human leukocyte antigen–identical sibling transplants for adults with leukemia T Hahn, PL McCarthy Jr, MJ Zhang, D Wang, M Arora, H Frangoul, ... Journal of Clinical Oncology 26 (35), 5728, 2008 | 250 | 2008 |
| Use of amniotic membrane transplantation in the treatment of venous leg ulcers I Mermet, N Pottier, JM Sainthillier, C Malugani, S Cairey‐Remonnay, ... Wound repair and regeneration 15 (4), 459-464, 2007 | 241 | 2007 |
| Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow … P Tiberghien, CW Reynolds, J Keller, S Spence, M Deschaseaux, ... | 240 | 1994 |
| Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease P Herve, M Flesch, P Tiberghien, J Wijdenes, E Racadot, P Bordigoni, ... | 221 | 1992 |
| Relevance of Toll-like receptor-4 polymorphisms in renal transplantation D Ducloux, M Deschamps, M Yannaraki, C Ferrand, J Bamoulid, P Saas, ... Kidney international 67 (6), 2454-2461, 2005 | 205 | 2005 |
| Collecting and evaluating convalescent plasma for COVID‐19 treatment: why and how? P Tiberghien, X de Lamballerie, P Morel, P Gallian, K Lacombe, ... Vox sanguinis 115 (6), 488-494, 2020 | 204 | 2020 |
| Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease D Bougard, JP Brandel, M Bélondrade, V Béringue, C Segarra, H Fleury, ... Science translational medicine 8 (370), 370ra182-370ra182, 2016 | 197 | 2016 |
| HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells Z Selmani, A Naji, E Gaiffe, L Obert, P Tiberghien, N Rouas-Freiss, ... Transplantation 87 (9S), S62-S66, 2009 | 195 | 2009 |
| Role of STAT3 in CD4+ CD25+ FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity JR Pallandre, E Brillard, G Créhange, A Radlovic, JP Remy-Martin, ... The Journal of Immunology 179 (11), 7593-7604, 2007 | 181 | 2007 |
| Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations H Oh, FR Loberiza Jr, M Zhang, O Ringdén, H Akiyama, T Asai, ... Blood 105 (4), 1408-1416, 2005 | 177 | 2005 |
| Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers MC Bittencourt, S Perruche, E Contassot, S Fresnay, MH Baron, ... Blood, The Journal of the American Society of Hematology 98 (1), 224-230, 2001 | 175 | 2001 |
